This inventor holds 1 USPTO granted patent. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: The Innovator Behind MicroRNA Research: Marina Lagos-Quintana
Introduction
Marina Lagos-Quintana, based in New York, NY, is a prominent inventor recognized for her significant contribution to the field of microRNA research. With her innovative approach, she has enhanced our understanding of how these small RNA molecules serve as critical regulators of developmental timing.
Latest Patents
Marina holds a patent that focuses on microRNA molecules. The patent details how lin-4 and let-7 encode 22- and 21-nucleotide RNAs, respectively, which function as essential regulators of developmental processes. Due to their ability to influence timing during development, they are referred to as 'small temporal RNAs' (stRNAs). Her research reveals the existence of many additional microRNAs in both invertebrates and vertebrates, uncovering a broader spectrum of sequence-specific post-transcriptional regulatory mechanisms than previously understood.
Career Highlights
Currently, Marina works at the Max Planck Society for the Advancement of the Sciences (Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.), a prestigious research institution known for its commitment to scientific innovation. Her work has garnered attention for its implications in developmental biology and genetic regulation, which may lead to further advancements in biotechnology and medicine.
Collaborations
Throughout her career, Marina has collaborated with notable researchers, including Thomas Tuschl and Winfried Lendeckel. Their combined expertise has contributed significantly to the advancement of microRNA research and its applications in various scientific fields.
Conclusion
Marina Lagos-Quintana's work exemplifies the spirit of innovation in scientific research. Her patent on microRNA molecules not only expands the current knowledge of genetic regulation but also paves the way for future studies and applications. As she continues her work at the Max Planck Society, her contributions are likely to inspire further exploration and innovation in the world of molecular biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile